The rapid development and growing accessibility of artificial intelligence (AI), and the expanding use of AI in the life sciences sector, are becoming increasingly important factors in the continuing evolution of pharmaceutical industry compliance, and government enforcement efforts.
But the use of AI comes with unanswered questions over its incorporation
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
